General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

A Resized Pharmacy Image cbOctober 11 2017

Pharmacy gave rise to 18% of complaints made against NHS Family Services providers in Scotland. 

 Annual statistics published by Information Services Division of NHS Scotland indicate that in 2016-17, that medical services (general practice) generated the most complaints, accounting for 65% of complaints made, pharmaceutical services for 18% and dental and ophthalmic services each accounting for 8%.

Overall, NHS Scotland complaints increased by 10% to 23,507 in 2016-17, with family health services complaints increasing by 14% to 7,660 in 2016-17.

There were 1,414 complaints about pharmacy services in 2016-17, the highest level since the data was first collected in 2012-13, when the number of complaints was 1,022. The increase of 20% between 2015-16 (1,177 complaints) and 2016-17 was the highest increase of a service. Medical service complaints were up 14% and ophthalmic complaints were up 14%, while complaints about dental services saw a 1% decrease.

The annual statistics are compiled from returns from health service providers. “The overall family health services contractor return rate for 2016-17 was 80%. For medical, dental, pharmaceutical and ophthalmic this equates to 92%, 79%, 69% and 66% respectively,” says the report.

Links:
ISD Scotland publications            
ISD NHSScotland Complaints Statistics 2016/17 Summary             
ISD NHSScotland Complaints Statistics 2016/17 Full report         

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...